European Archives - Page 206 of 1216 - European Medical Journal

Low Lymphocyte Count Linked to Poorer Survival in Multiple Myeloma

Low lymphocyte count at diagnosis and during treatment is associated with poorer survival in multiple myeloma patients.

GLP-1 Receptor Agonists Linked to Behavioural Side Effects

Diabetes treatments linked to behavioural side effects in new research.

Comparing Infant Formulas for Cow’s Milk Protein Allergy

Hydrolysed rice formulas offer unique advantages, such as accommodating cultural, religious, and economic preferences.

Advancing Haemophilia Care: An EAHAD Roundtable Discussion

Tune into the latest EMJ Webinar, featuring five key members of the European Association for Haemophilia and Allied Disorders (EAHAD), who join Jonathan Sackier to discuss the EAHAD’s mission, aims, and key projects for the coming year.

Electronic Noses and Breath Profiles for Diagnosing Disease

This infographic highlights the transformative potential of electronic noses (eNoses) in disease diagnosis, monitoring, and treatment…

GSK and Oxford unite to advance cancer vaccine research

The new collaboration between GSK and the Univeristy of Oxford aims to explore cancer prevention through vaccination.

Health Disparities in MASLD Among Hispanic Adults

Data from 22 studies, encompassing 756,088 subjects, including 62,072 Hispanic adults, revealed striking findings.

TRILUMINATE Imaging Substudy: Sustained Cardiac Remodelling with TriClip

New imaging data show TriClip reduces tricuspid regurgitation and reverses cardiac remodeling, sustaining benefits for one year.

Targeting MRI-Detected Inflammation Improves Axial Spondyloarthritis Management

A groundbreaking analysis of the ESTHER trial reveals that resolution of MRI-detected inflammation in the sacroiliac joints is strongly linked to improved clinical outcomes in patients with axial spondyloarthritis undergoing long-term anti-TNF therapy.

Non-Hormonal Therapies Reduce Menopause Symptoms

Elinzanetant and fezolinetant ease menopause symptoms, with elinzanetant improving sleep and reducing side effects.